By expenditures
| Name | Title | Type |
|---|---|---|
| Sheila Johnson | Assistant Superintendent of Finance & Operations | Auditee |
| Patrick King | DIRECTOR OF FINANCE | Auditee |
| Nick Cavaliere | Principal | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 341891 | 2024 | 2025-02-10 | Baker Tilly US LLP | $4.37M |
| 293479 | 2023 | 2024-03-05 | Baker Tilly US LLP | $5.16M |
| 30957 | 2022 | 2023-01-30 | Baker Tilly US LLP | $5.44M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 341891 | 2024 | 2025-02-10 | 1099086 | 2024-004 | Material Weakness | - | G |
| 341891 | 2024 | 2025-02-10 | 1099085 | 2024-004 | Material Weakness | - | G |
| 341891 | 2024 | 2025-02-10 | 1099084 | 2024-004 | Material Weakness | - | G |
| 341891 | 2024 | 2025-02-10 | 1099083 | 2024-004 | Material Weakness | - | G |
| 341891 | 2024 | 2025-02-10 | 522644 | 2024-004 | Material Weakness | - | G |
| 341891 | 2024 | 2025-02-10 | 522643 | 2024-004 | Material Weakness | - | G |
| 341891 | 2024 | 2025-02-10 | 522642 | 2024-004 | Material Weakness | - | G |
| 341891 | 2024 | 2025-02-10 | 522641 | 2024-004 | Material Weakness | - | G |
| 293479 | 2023 | 2024-03-05 | 948616 | 2023-002 | Material Weakness | - | AB |
| 293479 | 2023 | 2024-03-05 | 948615 | 2023-002 | Material Weakness | - | AB |
| 293479 | 2023 | 2024-03-05 | 372174 | 2023-002 | Material Weakness | - | AB |
| 293479 | 2023 | 2024-03-05 | 372173 | 2023-002 | Material Weakness | - | AB |
| 30957 | 2022 | 2023-01-30 | 612554 | 2022-006 | Material Weakness | - | AB |
| 30957 | 2022 | 2023-01-30 | 612553 | 2022-005 | Significant Deficiency | - | AB |
| 30957 | 2022 | 2023-01-30 | 612552 | 2022-004 | Material Weakness | - | I |
| 30957 | 2022 | 2023-01-30 | 612551 | 2022-003 | Significant Deficiency | - | L |
| 30957 | 2022 | 2023-01-30 | 612550 | 2022-005 | Significant Deficiency | - | AB |
| 30957 | 2022 | 2023-01-30 | 612549 | 2022-004 | Material Weakness | - | I |
| 30957 | 2022 | 2023-01-30 | 612548 | 2022-003 | Significant Deficiency | - | L |
| 30957 | 2022 | 2023-01-30 | 612547 | 2022-005 | Significant Deficiency | - | AB |
| 30957 | 2022 | 2023-01-30 | 612546 | 2022-004 | Material Weakness | - | I |
| 30957 | 2022 | 2023-01-30 | 612545 | 2022-003 | Significant Deficiency | - | L |
| 30957 | 2022 | 2023-01-30 | 612544 | 2022-005 | Significant Deficiency | - | AB |
| 30957 | 2022 | 2023-01-30 | 612543 | 2022-004 | Material Weakness | - | I |
| 30957 | 2022 | 2023-01-30 | 612542 | 2022-003 | Significant Deficiency | - | L |
| 30957 | 2022 | 2023-01-30 | 36112 | 2022-006 | Material Weakness | - | AB |
| 30957 | 2022 | 2023-01-30 | 36111 | 2022-005 | Significant Deficiency | - | AB |
| 30957 | 2022 | 2023-01-30 | 36110 | 2022-004 | Material Weakness | - | I |
| 30957 | 2022 | 2023-01-30 | 36109 | 2022-003 | Significant Deficiency | - | L |
| 30957 | 2022 | 2023-01-30 | 36108 | 2022-005 | Significant Deficiency | - | AB |
| 30957 | 2022 | 2023-01-30 | 36107 | 2022-004 | Material Weakness | - | I |
| 30957 | 2022 | 2023-01-30 | 36106 | 2022-003 | Significant Deficiency | - | L |
| 30957 | 2022 | 2023-01-30 | 36105 | 2022-005 | Significant Deficiency | - | AB |
| 30957 | 2022 | 2023-01-30 | 36104 | 2022-004 | Material Weakness | - | I |
| 30957 | 2022 | 2023-01-30 | 36103 | 2022-003 | Significant Deficiency | - | L |
| 30957 | 2022 | 2023-01-30 | 36102 | 2022-005 | Significant Deficiency | - | AB |
| 30957 | 2022 | 2023-01-30 | 36101 | 2022-004 | Material Weakness | - | I |
| 30957 | 2022 | 2023-01-30 | 36100 | 2022-003 | Significant Deficiency | - | L |